Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination

Mayo Clinic Proceedings

Volumn 90, Issue 7, 2015, Pages 865-873

  Cheetham, T Craig ^a   Marcy, S Michael ^a   Tseng, Hung Fu ^a   Sy, Lina S ^a   Liu, In Lu Amy ^a   Bixler, Felicia ^a   Baxter, Roger ^b   Donahue, James G ^c   Naleway, Allison L ^a   Jacobsen, Steven J ^a  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; VARICELLA ZOSTER VACCINE;

AGED; CLINICAL TRIAL; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; IMMUNOLOGY; MALE; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VACCINATION; VARICELLA ZOSTER VIRUS;

AGED; FEMALE; FOLLOW-UP STUDIES; HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VACCINATION;

EID: 84934444291     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.04.021     Document Type: Article

References (27)

1. Zostavax [package insert]. Whitehouse Station, NJ: Merck & Co Inc; 2014.
2. M.N. Oxman, M.J. Levin, G.R. Johnson, and et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 22 2005 2271 2284
3. H.F. Tseng, N. Smith, R. Harpaz, S.R. Bialek, L.S. Sy, and S.J. Jacobsen Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease JAMA 305 2 2011 160 166
4. S.M. Langan, L. Smeeth, D.J. Margolis, and S.L. Thomas Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study PLoS Med 10 4 2013 e1001420
5. D.J. Weber, and W.A. Rutala Immunization of immunocompromised persons Immunol. Allergy Clin North Am 23 4 2003 605 634
6. Institute of Medicine Varicella virus vaccine K. Stratton, A. Ford, E. Rusch, and E. Wright, eds. Adverse Effects of Vaccines: Evidence and Causality 2012 National Academies Press Washington, DC 239 292
7. H.F. Tseng, D.S. Schmid, R. Harpaz, and et al. Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine Clin Infect Dis 58 8 2014 1125 1128
8. J.I. Cohen Strategies for herpes zoster vaccination of immunocompromised patients J Infect Dis 197 suppl 2 2008 S237 S241
9. R.J. Whitley, and J.W. Gnann Jr. Herpes zoster in the age of focused immunosuppressive therapy JAMA 301 7 2009 774 775
10. K.L. Winthrop, and D.E. Furst Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy Ann Rheum Dis 69 10 2010 1735 1737
11. L.G. Rubin, M.J. Levin, P. Ljungman, and et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host Clin Infect Dis 58 3 2014 309 318
12. R. Harpaz, I.R. Ortega-Sanchez, and J.F. Seward Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 57 RR-5 2008 1 30 quiz CE2-4
13. B.P. Yawn, P. Saddier, P.C. Wollan, J.L. St Sauver, M.J. Kurland, and L.S. Sy A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction Mayo Clin Proc 82 11 2007 1341 1349
14. A.L. Smitten, H.K. Choi, M.C. Hochberg, and et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom Arthritis Rheum 57 8 2007 1431 1438
15. F. Wolfe, K. Michaud, and E.F. Chakravarty Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders Rheumatology (Oxford) 45 11 2006 1370 1375
16. G. Gupta, E. Lautenbach, and J.D. Lewis Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease Clin Gastroenterol Hepatol 4 12 2006 1483 1490
17. E.F. Borba, A.C. Ribeiro, P. Martin, L.P. Costa, L.K. Guedes, and E. Bonfa Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus J Clin Rheumatol 16 3 2010 119 122
18. E.F. Chakravarty, K. Michaud, R. Katz, and F. Wolfe Increased incidence of herpes zoster among patients with systemic lupus erythematosus Lupus 22 3 2013 238 244
19. H.B. Park, K.C. Kim, J.H. Park, and et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus J Rheumatol 31 11 2004 2151 2155
20. A. Strangfeld, J. Listing, P. Herzer, and et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents JAMA 301 7 2009 737 744
21. K.L. Winthrop, J.W. Baddley, L. Chen, and et al. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster JAMA 309 9 2013 887 895
22. N. Zhang, S. Wilkinson, M. Riaz, A.J. Ostor, and M.K. Nisar Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? a systematic literature review Clin Exp Rheumatol 30 6 2012 962 971
23. J. Zhang, F. Xie, E. Delzell, and et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases JAMA 308 1 2012 43 49
24. J. Baggs, J. Gee, E. Lewis, and et al. The Vaccine Safety Datalink: a model for monitoring immunization safety Pediatrics 127 suppl 1 2011 S45 S53
25. B.P. Yawn, P. Wollan, and J. St Sauver Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol 174 9 2011 1054 1061
26. T. Kurth, A.M. Walker, R.J. Glynn, and et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect Am J Epidemiol 163 3 2006 262 270
27. P.C. Austin The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk recuctions) in observational studies Statist Med 29 20 2010 2137 2148